Personalis, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage
Personalis, Inc. (PSNL) reported Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage of 25.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage · last filed 2026-08-04
- Personalis, Inc. share-based compensation arrangement by share-based payment award, award vesting rights, percentage for the quarter ending 2026-03-31 was 25.00%.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, award vesting rights, percentage for the quarter ending 2021-03-31 was 25.00%.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, award vesting rights, percentage for fiscal 2025 was 25.00%, a 0.00% change from fiscal 2024.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, award vesting rights, percentage for fiscal 2024 was 25.00%, a 0.00% change from fiscal 2023.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, award vesting rights, percentage for fiscal 2023 was 25.00%, a 0.00% change from fiscal 2022.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, award vesting rights, percentage for fiscal 2022 was 25.00%, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 12 month |
|---|---|---|---|---|
| 2026-06-30 | 25.00% 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 25.00% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 25.00% 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 25.00% 10-K · filed 2025-02-27 | |||
| 2023-12-31 | 25.00% 10-K · filed 2024-02-28 | |||
| 2022-12-31 | 25.00% 10-K · filed 2023-02-23 | |||
| 2021-12-31 | 25.00% 10-K · filed 2022-02-24 | |||
| 2021-09-30 | 25.00% 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | 25.00% 10-Q · filed 2021-08-04 | |||
| 2021-03-31 | 25.00% 10-Q · filed 2021-05-05 | |||
| 2020-12-31 | 25.00% 10-K · filed 2021-02-25 | |||
| 2020-09-30 | 25.00% 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 25.00% 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |